Darshan Kulkarni
Regulatory and Compliance Attorney for the Life Sciences, The Kulkarni Law Firm
Darshan Kulkarnisecurehost2025-04-04T14:19:41+00:00
APRIL 2025
In this DHCG Disruptive Dose, Mark Bard of the DHC Group and Darshan Kulkarni, Regulatory and Compliance Attorney for the Life Sciences at The Kulkarni Law Firm, dive into the evolving role of pharma in direct-to-consumer and direct-to-patient models. As companies bypass traditional intermediaries like PBMs and GPOs, new challenges arise in education, prescribing, liability, and distribution. They explore critical questions: Who truly owns the patient relationship? How will regulatory shifts impact pharma’s expanding role? And what happens when AI and virtual care disrupt traditional pharmacy models? Darshan shares his expert take on the legal, compliance, and strategic risks that will shape the industry’s future.